The coccidian parasite *Neospora caninum* (Apicomplexa: Sarcocystidae) is a major abortifacient agent in ruminants, especially cattle. It is phylogenetically close to *Toxoplasma gondii* ([@R1]), a parasite of high prevalence in humans, but biologically different. *N. caninum* parasites have a restricted host range but can infect primates ([@R2]*,*[@R3]).

*N. caninum* infection causes neuromuscular disease in dogs and reproductive disorders in ruminants, causing fetal loss due to vertical transfer of parasites during acute infections or reactivation of chronic infections. Clinical neosporosis in animals resembles the disease outcome of toxoplasmosis ([@R1]).

*N. caninum* parasites have been successfully cultured in human cell lines, but low antibody titers of unconfirmed specificity against *N. caninum* have been reported in human serum samples ([@R1],[@R4],[@R5]). The significance of these findings is uncertain because neither parasite DNA nor viable parasites have been demonstrated in human tissues. Unconfirmed reports of *N. caninum*--specific antibodies in the human population ([@R4]*,*[@R5]) prompted us to test specifically for *Neospora* DNA in human clinical specimens and assess its possible role in human illness.

We obtained 600 DNA samples from a collection of anonymized human clinical samples from the National Registry of Biobanks (no. C.0004715) in Spain that were deemed exempt from a second ethics approval. Our criteria for selection included any pregnancy-related disorder affecting women or fetuses, toxoplasmosis-like clinical signs or suspicion of toxoplasmosis, and negative results for *T. gondii*--specific real-time PCR ([@R6]) and nested PCR ([@R7]) ([Table](#T1){ref-type="table"}).

###### Types of samples analyzed and demographic and clinical data for 600 patients tested for *Neospora caninum* parasites, Spain\*

  Characteristics            No. (%)
  -------------------------- ------------
  Blood                      100 (16.7)
  Placental tissue           51 (8.5)
  Bronchoalveolar lavage     25 (4.2)
  Urine                      17 (2.8)
  Brain biopsy               12 (2.0)
  Aqueous humor              4 (0.7)
  Fetal tissues and fluids   4 (0.7)
  Lymph node aspirate        3 (0.5)
  Vitreous humor             2 (0.3)
  Bone marrow aspirate       1 (0.2)
  Hepatic abscess aspirate   1 (0.2)

  Patient demographic information   
  --------------------------------- ------------
  Sex                               
  Unknown                           6 (1.0)
  M                                 135 (22.5)
  F                                 459 (76.5)
  Of childbearing age, 17--42 y     333 (55.5)
  Age, y                            
  \>1, average 36.1                 481 (80.2)
  \<1                               116 (19.3)

  Native country                                              
  ----------------------------------------------------------- ------------
  Spain                                                       382 (63.7)
  Other†                                                      36 (6.0)
  Unknown                                                     182 (30.3)
  Patient clinical information                                
  Immune status                                               
  Immunocompetent                                             458 (76.3)
  Immunodepressed or   immunosuppressed                       83 (13.8)
  HIV/AIDS                                                    19 (22.9)
  Chemotherapy                                                29 (34.9)
  Organ transplant                                            35 (42.2)
  Unknown                                                     59 (9.8)
  Pregnancy-related disorders                                 454 (75.7)
  Seroconversion--infection suspicion   and lymphadenopathy   418 (92.1)
  Spontaneous abortion                                        27 (5.9)
  Ophthalmic                                                  4 (0.9)
  Other fetal signs‡                                          5 (1.1)
  Neurologic and ocular symptoms and   conditions§            108 (18.0)
  Neurologic condition with ocular signs                      8 (7.4)
  Ophthalmic only                                             3 (2.7)
  General signs, n = 38                                       38 (6.3)
  Pneumonia                                                   24 (63.2)
  Lymphadenopathy                                             2 (5.3)
  Hematologic or oncologic                                    12 (31.6)

\*Patients were from 12 regions: Andalusia, Aragon, Asturias, Balearic Islands, Cantabria, Castile-La Mancha, Castile and Leon, Extremadura, Galicia, Madrid, Navarre, Valencia.  †Africa, 8; Asia, 1; Europe, 8; Latin America, 19. ‡Anencephaly, malformations, and microcephaly. §Neurologic symptoms and conditions include ataxia, disorientation, sudden blindness, encephalitis, calcifications, and intracranial space occupying lesions; ophthalmic symptoms and conditions include chorioretinitis, panuveitis, posterior uveitis, and vitritis.

We isolated total DNA using a QIAamp DNA Mini Kit (QIAGEN, <https://www.qiagen.com>) and used a single-tube nested PCR to amplify the *N. caninum* internal transcribed spacer 1 region using external primers NN1--NN2 and internal primers NP1--NP2, as previously described ([@R8],[@R9]). We expected a diagnostic 249-bp fragment. In each batch of amplifications, positive PCR controls included genomic DNA of 10, 1, and 0.1 *N. caninum* tachyzoites. Using these PCR methods, we found that the analytical sensitivity was \<1 tachyzoite of *Neospora* spp. or *T. gondii*.

We did not detect *N. caninum*--specific DNA in the samples analyzed. Previously, transplacental neosporosis was experimentally demonstrated in rhesus macaques (*Macaca mulatta*) in the United States ([@R2],[@R3]). A literature review summarized reports of unconfirmed presence of antibodies against *N. caninum* in patients with neurologic disorders, pregnant women, and healthy people, including blood donors ([@R1]). Findings of *N. caninum* IgG in HIV-infected patients from Brazil and France ([@R4],[@R5]) are of special interest because of possible association with *T. gondii* infections.

We believe *N. caninum* parasites are an unlikely opportunistic zoonotic agent. Application of direct methods for parasite detection in a greater number of samples from HIV-positive patients should complement unclear serologic findings to fully dispel suspicion of human neosporosis.
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